Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil

Copyright
open access
Type
Article
Date
2016
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Alternative Title
Affilliation
Advisor
Co-Advisor
Committee Member
Organizer
Coordinator(s)
Institutional author
Director
item.page.production
Screenplay
Producer
Recorder
Abstract
Summary Anti-tuberculosis (TB) drugs are responsible for the occurrence of several adverse drug reactions (ADRs), including hepatotoxicity. The aim was to estimate the incidence of hepatotoxicity and its association with genetic polymorphisms and clinical-epidemiological factors by comparing indigenous and non-indigenous TB patients. We investigated clinical-epidemiological variables, serum levels of liver enzymes and NAT2, CYP2E1 and GSTM1 polymorphisms. A non-conditional logistic regression was used to identify the factors associated with hepatotoxicity. Odds ratios were used as the association measures. The incidence of hepatotoxicity was 19.7% for all patients. The risk of hepatotoxicity was almost four times higher in indigenous patients, comparing to non-indigenous. We identified a new nonsynonymous single nucleotide polymorphism of NAT2 in indigenous patients. In total, 54.6% of the patients expressed a slow acetylation phenotype profile. The frequency of the null genotype of GSTM1 was higher in non-indigenous patients (p = 0.002), whereas no significant differences in relation to polymorphisms of CYP2E1 were observed between the groups. Hepatotoxicity was associated with patients older than 60 and indigenous (OR = 26.0; 95%CI:3.1–217.6; OR = 3.8; 95%CI:1.3–11.1, respectively). Furthermore, hepatotoxicity was associated with a slow acetylation profile in indigenous patients (OR = 10.7; 95%CI:1.2–97.2). Our findings suggest that there are distinct acetylation profiles in the Brazilian population, emphasizing the importance of pharmacogenetic analyses for achieving personalized therapeutic schemes and better outcomes.
Abstract
Abstract in Spanish
Abstract in French
Description
Keywords in Portuguese
Keywords
Brazil, Health of Indigenous Peoples, Indians, South American, Tuberculosis, Pharmacogenetics, Adverse Drug Reactions, Hepatotoxicit
Keywords in Spanish
Keywords in French
DeCS
Brasil, Saúde de Populações Indígenas, Índios Sul-Americanos, Epidemiologia, Tuberculose, Genética Humana, Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
Event Date
Previous version
Related Document
Means of dissemination
Duration
Duration
Original color system
Target audience context
Audience occupation
Educational Description
Evaluation
Peer Reviewed
Publication Status
Sponsorship
Latest version
Version
Event Location
Event title
Event Type
Citation
HEINRICH, Melissa M.; ZEMBRZUSKI, Verônica M.; OTA, Marcos M.; SACCHI, Flavia P.; TEIXEIRA, Raquel L. F.; CABELLO ACERO, Pedro H.; CUNHA, Geraldo Marcelo; SOUZA-SANTOS, Reinaldo; CRODA, Julio; BASTA, Paulo C.. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil. Tuberculosis, v. 101, p. 15-24, 2016
ISBN
ISSN
1472-9792
DOI
10.1016/j.tube.2016.07.006
Defense Institution
Degree date
Defense location
Programa